Loos U - Search Results

1

[Intravenous rifampicin therapy in open tuberculosis].

Loos U, Musch E, Mackes KG, Reetz KP, Gläser R, Schwabe HK, Hengstmann J, Eichelbaum M. Loos U, et al. Med Welt. 1983 Jun 17;34(24):701-3. Med Welt. 1983. PMID: 6888237 Clinical Trial. German. No abstract available.

2

[Clinico-pharmacokinetic interactions of rifampicin, pyrazinamide and isoniazide].

Musch E, Loos U, Schwabe HK. Musch E, et al. Among authors: loos u. Pneumologie. 1990 Feb;44 Suppl 1:486-7. Pneumologie. 1990. PMID: 2367444 German.

3

[Significance of the acetylator phenotype and initial oral/intravenous rifampicin administration in the treatment of tuberculosis].

Loos U, Musch E, Schwabe HK. Loos U, et al. Pneumologie. 1990 Feb;44 Suppl 1:488-9. Pneumologie. 1990. PMID: 2367445 German.

4

Influence of the enzyme induction by rifampicin on its presystemic metabolism.

Loos U, Musch E, Jensen JC, Schwabe HK, Eichelbaum M. Loos U, et al. Pharmacol Ther. 1987;33(1):201-4. doi: 10.1016/0163-7258(87)90052-0. Pharmacol Ther. 1987. PMID: 3628475 No abstract available.

5

Pharmacokinetics of oral and intravenous rifampicin during chronic administration.

Loos U, Musch E, Jensen JC, Mikus G, Schwabe HK, Eichelbaum M. Loos U, et al. Klin Wochenschr. 1985 Dec 2;63(23):1205-11. doi: 10.1007/BF01733779. Klin Wochenschr. 1985. PMID: 4087830 Clinical Trial.

6

[Comparison of oral and intravenous rifampicin administration in the treatment of open pulmonary tuberculosis].

Loos U, Musch E, Mackes KG, Reetz KP, Gläser R, von Sassen W, Labedzki L, Schwabe HK, Hengstmann J, Eichelbaum M. Loos U, et al. Prax Klin Pneumol. 1983 Oct;37 Suppl 1:482-4. Prax Klin Pneumol. 1983. PMID: 6647280 Clinical Trial. German. No abstract available.

7

The pharmacokinetics of melphalan during intermittent therapy of multiple myeloma.

Loos U, Musch E, Engel M, Hartlapp JH, Hügl E, Dengler HJ. Loos U, et al. Eur J Clin Pharmacol. 1988;35(2):187-93. doi: 10.1007/BF00609251. Eur J Clin Pharmacol. 1988. PMID: 3191937

8

Comparative pharmacokinetics of chlorambucil and prednimustine after oral administration.

Loos U, Musch E, Malek M, Riedel E. Loos U, et al. Oncology. 1991;48(4):334-42. doi: 10.1159/000226953. Oncology. 1991. PMID: 1891177 Clinical Trial.

9

[Bronchopulmonary penetration of ciprofloxacin].

Loos U, Marklein G, Scholl H, Schwabe HK. Loos U, et al. Pneumologie. 1990 Feb;44 Suppl 1:312-3. Pneumologie. 1990. PMID: 2367402 German.

10

Relevance of the hydrolysis and protein binding of melphalan to the treatment of multiple myeloma.

Gera S, Musch E, Osterheld HK, Loos U. Gera S, et al. Among authors: loos u. Cancer Chemother Pharmacol. 1989;23(2):76-80. doi: 10.1007/BF00273521. Cancer Chemother Pharmacol. 1989. PMID: 2910515

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page